Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Dec 21;481(7381):376-9.
doi: 10.1038/nature10718.

T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction

Affiliations

T-cell differentiation factor CBF-β regulates HIV-1 Vif-mediated evasion of host restriction

Wenyan Zhang et al. Nature. .

Abstract

The human APOBEC3 cytidine deaminases are potent inhibitors of diverse retroviruses, including human immunodeficiency virus-1 (HIV-1). HIV-1 Vif forms an E3 ubiquitin ligase complex with cullin 5 (CUL5), elongin B and elongin C , which promotes the polyubiquitination and degradation of APOBEC3 substrates. Here we demonstrate in human T cells that core binding factor β (CBF-β) is a key regulator of the evasion of HIV-1 from the host defence mediated by APOBEC3. CBF-β, the non-DNA-binding subunit of a heterodimeric transcription factor, regulates the folding and DNA-binding activity of partner RUNX family proteins, which have important roles in the development and differentiation of diverse cell types, including T lymphocytes. In our study, knockdown of endogenous CBF-β blocked Vif-induced APOBEC3G polyubiquitination and degradation. CBF-β was not required for the interaction between Vif and APOBEC3G, yet was essential for the assembly of the Vif-CUL5 E3-ubiquitin-ligase complex. CBF-β proved to be a unique regulator of primate lentiviral Vif and not a general component of the CUL5 E3 ubiquitin ligase. We show that Vif and CBF-β physically interact, and that the amino-terminal region of Vif is required for this interaction. Furthermore, interactions with Vif required regions in CBF-β that are not involved in RUNX protein binding. Considering the importance of the interaction between Vif and CBF-β, disrupting this interaction represents an attractive pharmacological intervention against HIV-1.

PubMed Disclaimer

Comment in

  • HIV: Tagged for destruction.
    Molloy S. Molloy S. Nat Rev Microbiol. 2012 Jan 16;10(2):81. doi: 10.1038/nrmicro2739. Nat Rev Microbiol. 2012. PMID: 22245926 No abstract available.

Similar articles

Cited by

References

    1. Genes Dev. 2004 Dec 1;18(23):2867-72 - PubMed
    1. Mol Cell. 2003 Sep;12(3):591-601 - PubMed
    1. J Biol Chem. 2004 Feb 27;279(9):7792-8 - PubMed
    1. Nat Med. 2003 Nov;9(11):1404-7 - PubMed
    1. Retrovirology. 2008 Jun 24;5:51 - PubMed

Publication types

MeSH terms